Stock CVLB VALE S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Vale S.A. Bulgaria S.E.

Equities

CVLB

US91912E1055

End-of-day quote Bulgaria S.E.
Other stock markets
 18:00:00 2024-06-10 EDT 		5-day change 1st Jan Change
10.45 EUR -0.95% Intraday chart for Vale S.A. 0.00% -27.43%
06-24 Brazil prosecutors seek $668 million from Vale, BHP for gender violations in reparations RE
06-21 Morgan Stanley Adjusts Vale Price Target to $15.50 From $18, Maintains Overweight Rating MT

Evolution of the average Target Price on Vale S.A.

Price target over the last 5 years

History of analyst recommendation changes

ebcdbd303bf22a160f.sfdJEIrU-ohuDBLlIKDU_YWAf7vh-t5KzNJb-xzDifE.-YIuWbPlv7oYOludSZK8y-34M9_QyetzpeYXt26F-ZLwqHB9zJmT5wpuXw~02100d5335430d61c219e2e1a5b88ea8

Analyst Recommendations on Vale S.A.

Morgan Stanley Adjusts Vale Price Target to $15.50 From $18, Maintains Overweight Rating MT
BNP Paribas Exane Upgrades Vale to Neutral From Underperform, Price Target is $12.70 MT
RBC Trims Price Target on Vale to $18 From $18.50, Keeps Outperform Rating MT
UBS Upgrades Vale to Buy From Neutral, Raises Price Target to $15 From $13 MT
Barclays Raises Price Target on Vale to $17 From $16, Keeps Overweight Rating MT
JPMorgan Trims Price Target on Vale to $20 From $20.50, Maintains Overweight Rating MT
UBS Lowers Vale's Price Target to $13 From $15, Maintains Neutral Rating MT
RBC Trims Price Target on Vale to $18.50 From $19, Keeps Outperform Rating MT
UBS Adjusts Vale Price Target to $15 From $14, Maintains Neutral Rating MT
Barclays Adjusts Vale Price Target to $15 From $16, Maintains Overweight Rating MT
RBC Raises Price Target on Vale to $16 From $15, Keeps Outperform Rating MT
JPMorgan Raises Vale Price Target to $19 From $17.50, Maintains Overweight Rating MT
Goldman Sachs Upgrades Vale to Buy From Neutral, Adjusts Price Target to $19.50 From $12.20 MT
BofA Securities Upgrades Vale to Buy From Neutral, Price Target is $20 MT
Deutsche Bank Downgrades Vale to Hold From Buy, Trims Price Target to $17 From $18 MT
RBC Lifts Price Target on Vale to $15 From $14, Keeps Outperform Rating MT
RBC Raises Price Target on Vale to $15 From $14, Keeps Outperform Rating MT
UBS Upgrades Vale to Neutral From Sell, Adjusts Price Target to $14 From $13 MT
JPMorgan Raises Vale Price Target to $18 From $16, Maintains Overweight Rating MT
JPMorgan Upgrades Vale to Overweight From Neutral, Adjusts Price Target to $16 From $15 MT
RBC Cuts Price Target on Vale to $14 From $15, Keeps Outperform Rating MT
Wolfe Research Upgrades Vale to Outperform From Peer Perform, Price Target is $17 MT
Scotiabank Downgrades Vale to Sector Perform From Sector Outperform, Cuts Price Target to $16 From $20 MT
BNP Paribas Exane Downgrades Vale to Underperform From Neutral MT
Morgan Stanley Trims Vale's Price Target to $17 From $18, Maintains Overweight Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
11.14 USD
Average target price
14.53 USD
Spread / Average Target
+30.37%
High Price Target
18.58 USD
Spread / Highest target
+66.68%
Low Price Target
8.258 USD
Spread / Lowest Target
-25.90%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Vale S.A.

Morgan Stanley
BNP Paribas Exane
RBC Capital Markets
UBS
Barclays
JPMorgan Chase
Goldman Sachs
BofA Securities
Deutsche Bank Securities
Wolfe Research
Scotiabank
BMO Capital
Jefferies & Co.
HSBC
Exane BNP Paribas

Ratings for Vale S.A.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. VALE3 Stock
  4. CVLB Stock
  5. Consensus Vale S.A.